Immunization

In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.

In part 2 of our interview, Lee Rosebush offers pharmacist-centered guidance on regulation and compliance amid COVID-19 vaccinations.

Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.

The MJH Life Sciences™ COVID-19 Coalition is hosting a live webinar event on the legal and ethical considerations of COVID-19 vaccination.

The US government has purchased 100 million more vaccine doses for COVID-19 to stay ahead of increasing demand.

Preventive efforts, renewed interest in vaccinations drive milder flu season.

The survey results also showed an increasing willingness among Americans to receive the vaccine.

The FDA advisory committee will meet in 3 weeks to discuss the Janssen investigational vaccine.

Pharmacists can employ several strategies to enhance these programs.

Starting February 11, federal vaccine supplies will be delivered directly to select pharmacies, according to the announcement.

The single-dose adenovirus-based vaccine candidate produced protective effects against moderate-to-severe COVID-19, as well as against multiple virus variants.

Experts presented safety data on the 2 currently authorized COVID-19 vaccines during a meeting of the CDC’s Advisory Committee on Immunization Practices.

The CDC’s Advisory Committee on Immunization Practices issued updates to its interim recommendations for mRNA COVID-19 vaccines.

The Biden administration announced efforts to boost COVID-19 vaccination supply and increase transparency.

A survey from APhA reported that the majority of pharmacists plan to or have received a COVID-19 vaccine.

Drug Topics interviews Naomi Lopez, director of healthcare policy at the Goldwater Institute, focusing on expanding scope of practice and COVID-19 vaccine candidates already being used in other countries.

In a letter to President Joe Biden, ASHP and more than 50 signers called for use of federal resources and expansion of the vaccinator workforce to confront the slow ramping up of COVID-19 vaccinations.

ISMP identified the most commonly reported errors and hazards associated with the new COVID-19 vaccines.

President-elect Joe Biden revealed his COVID-19 plan, which includes a disciplined focus on vaccination efforts.

Perry Cohen, Drug Topics Editorial Advisory Board member, discusses key trends in hospital and community pharmacy settings.

In a final briefing, OWS recommended states expand vaccination to all individuals 65 and older or those with comorbidities.

Study concludes vaccine significantly reduces risk of herpes zoster.

Moderna is upping its COVID-19 vaccine production this year, with a baseline estimation of 600 million doses for 2021.

In a statement, FDA officials recommended that all health care professionals continue to adhere to the FDA-authorized dosing and schedules of the COVID-19 vaccines.

With support from Operation Warp Speed and the National Institutes of Health, the study will evaluate the safety and efficacy of NVX-CoV2373.

Here are some of the top-read FDA approvals covered by Drug Topics® from this year.

The Drug Topics® team rounded up some of our top-read articles from the last year.

The FDA has authorized the Moderna mRNA vaccine for emergency use, making it the second vaccine for COVID-19.

Extra vaccine multidose vials may boost the country’s supply by millions of doses.

US health care workers have started receiving the COVID-19 vaccine, but we are still months away from approving the vaccine for use in children, according to Fauci.